Report says GLP-1 supply has shifted from shortage to stability
The account describes a market no longer defined by the shortages that drove mass compounding of semaglutide and tirzepatide.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 20 12:32 ETSource: Florida Today
The wire
- 01Florida Today reports that the GLP-1 market has largely moved from shortage conditions to stability.
- 02Supply status governs whether compounders may legally prepare copies of semaglutide and tirzepatide, so stability narrows the opening telehealth and 503A/503B operators have relied on.
- 03No underlying FDA shortage-list action is cited in the item; readers should check the agency's current drug shortage database before drawing conclusions.
From the source
Read at floridatoday.comThe GLP-1 Market Has Largely Moved From Shortage to Stability
